Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Trump vows no more attacks by Israel on Iran gas field after it 'violently lashed out'
Saudi Arabia trust with Iran hard to 're-establish', foreign minister says
QatarEnergy says several LNG facilities targeted by missiles, fires contained
Kuwait foils terror plot targeting vital facilities
Qatar declares Iranian attachés 'persona non grata'
